Average cost-effectiveness ratio with censored data

Heejung Bang, Hongwei Zhao

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

In cost-effectiveness analysis, interest could lie foremost in the incremental cost-effectiveness ratio (ICER), which is the ratio of the incremental cost to the incremental benefit of two competing interventions. The average cost-effectiveness ratio (ACER) is the ratio of the cost to benefit of an intervention without reference to a comparator. A vast literature is available for statistical inference of the ICERs, but limited methods have been developed for the ACERs, particularly in the presence of censoring. Censoring is a common feature in prospective studies, and valid analyses should properly adjust for censoring in cost as well as in effectiveness. In this article, we propose statistical methods for constructing a confidence interval for the ACER from censored data. Different methodsFieller, Taylor, bootstrapare proposed, and through simulation studies and data analysis, we address the performance characteristics of these methods.

Original languageEnglish (US)
Pages (from-to)401-415
Number of pages15
JournalJournal of Biopharmaceutical Statistics
Volume22
Issue number2
DOIs
StatePublished - Mar 1 2012

Fingerprint

Average Cost
Cost-effectiveness
Censored Data
Cost-Benefit Analysis
Censoring
Costs
Costs and Cost Analysis
Method of Characteristics
Statistical Inference
Statistical method
Confidence interval
Data analysis
Simulation Study
Prospective Studies
Confidence Intervals
Valid

Keywords

  • Bootstrap
  • Confidence interval
  • Fieller
  • Taylor

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology
  • Statistics and Probability

Cite this

Average cost-effectiveness ratio with censored data. / Bang, Heejung; Zhao, Hongwei.

In: Journal of Biopharmaceutical Statistics, Vol. 22, No. 2, 01.03.2012, p. 401-415.

Research output: Contribution to journalArticle

@article{92d2c5c6ef3141209d784c2d0a5fd038,
title = "Average cost-effectiveness ratio with censored data",
abstract = "In cost-effectiveness analysis, interest could lie foremost in the incremental cost-effectiveness ratio (ICER), which is the ratio of the incremental cost to the incremental benefit of two competing interventions. The average cost-effectiveness ratio (ACER) is the ratio of the cost to benefit of an intervention without reference to a comparator. A vast literature is available for statistical inference of the ICERs, but limited methods have been developed for the ACERs, particularly in the presence of censoring. Censoring is a common feature in prospective studies, and valid analyses should properly adjust for censoring in cost as well as in effectiveness. In this article, we propose statistical methods for constructing a confidence interval for the ACER from censored data. Different methodsFieller, Taylor, bootstrapare proposed, and through simulation studies and data analysis, we address the performance characteristics of these methods.",
keywords = "Bootstrap, Confidence interval, Fieller, Taylor",
author = "Heejung Bang and Hongwei Zhao",
year = "2012",
month = "3",
day = "1",
doi = "10.1080/10543406.2010.544437",
language = "English (US)",
volume = "22",
pages = "401--415",
journal = "Journal of Biopharmaceutical Statistics",
issn = "1054-3406",
publisher = "Taylor and Francis Ltd.",
number = "2",

}

TY - JOUR

T1 - Average cost-effectiveness ratio with censored data

AU - Bang, Heejung

AU - Zhao, Hongwei

PY - 2012/3/1

Y1 - 2012/3/1

N2 - In cost-effectiveness analysis, interest could lie foremost in the incremental cost-effectiveness ratio (ICER), which is the ratio of the incremental cost to the incremental benefit of two competing interventions. The average cost-effectiveness ratio (ACER) is the ratio of the cost to benefit of an intervention without reference to a comparator. A vast literature is available for statistical inference of the ICERs, but limited methods have been developed for the ACERs, particularly in the presence of censoring. Censoring is a common feature in prospective studies, and valid analyses should properly adjust for censoring in cost as well as in effectiveness. In this article, we propose statistical methods for constructing a confidence interval for the ACER from censored data. Different methodsFieller, Taylor, bootstrapare proposed, and through simulation studies and data analysis, we address the performance characteristics of these methods.

AB - In cost-effectiveness analysis, interest could lie foremost in the incremental cost-effectiveness ratio (ICER), which is the ratio of the incremental cost to the incremental benefit of two competing interventions. The average cost-effectiveness ratio (ACER) is the ratio of the cost to benefit of an intervention without reference to a comparator. A vast literature is available for statistical inference of the ICERs, but limited methods have been developed for the ACERs, particularly in the presence of censoring. Censoring is a common feature in prospective studies, and valid analyses should properly adjust for censoring in cost as well as in effectiveness. In this article, we propose statistical methods for constructing a confidence interval for the ACER from censored data. Different methodsFieller, Taylor, bootstrapare proposed, and through simulation studies and data analysis, we address the performance characteristics of these methods.

KW - Bootstrap

KW - Confidence interval

KW - Fieller

KW - Taylor

UR - http://www.scopus.com/inward/record.url?scp=84863150175&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863150175&partnerID=8YFLogxK

U2 - 10.1080/10543406.2010.544437

DO - 10.1080/10543406.2010.544437

M3 - Article

C2 - 22251182

AN - SCOPUS:84863150175

VL - 22

SP - 401

EP - 415

JO - Journal of Biopharmaceutical Statistics

JF - Journal of Biopharmaceutical Statistics

SN - 1054-3406

IS - 2

ER -